Dr. Greenwald is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 E Victoria St
Santa Barbara, CA 93101Phone+1 805-563-0041
Education & Training
- Stanford Health CareFellowship, Hematology and Medical Oncology, 2004 - 2007
- Stanford Health Care-Sponsored Stanford UniversityChief Residency, Internal Medicine, 2003 - 2004
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2000 - 2003
- Stanford University School of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2001 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 47 citationsUblituximab (TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory ...Jeff P. Sharman, Charles M. Farber, Daruka Mahadevan, Marshall T. Schreeder, Heather D. Brooks
British Journal of Haematology. 2017-02-01 - 8 citationsPhase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma.Loretta J Nastoupil, John Kuruvilla, Julio C Chavez, Fontanet Bijou, Thomas E Witzig
Ejhaem. 2022-05-01 - 105 citationsAcalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study.Roger G. Owen, Helen McCarthy, Simon Rule, Shirley D'Sa, Sheeba K. Thomas
The Lancet. Haematology. 2020-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: